Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fluticasone furoate
- Development stage
- Approved
- Lead developer
- GSK
- Modality
- Small Molecules
- Administration
- Intranasal, Inhalation
01
Overview
Fluticasone furoate is a synthetic, trifluorinated corticosteroid with potent anti-inflammatory activity. It is a glucocorticoid receptor agonist that modulates the expression of genes involved in the inflammatory response, leading to the inhibition of multiple cell types (such as mast cells, eosinophils, and lymphocytes) and the release of inflammatory mediators like histamine, cytokines, and leukotrienes. AVAFLUT is a generic formulation of fluticasone furoate developed and marketed by OSL Pharma in Bangladesh, primarily indicated for the management of symptoms associated with seasonal and perennial allergic rhinitis. It is also available in inhalation formats for the maintenance treatment of asthma.
- Brand names
- AVAFLUTAvamysVeramystArnuity Ellipta
- Other names
- fluticasone furoate
02
Targets
ER (Estrogen receptor)AR (Adrenergic receptors)PR (Progesterone receptor)GR (Glucocorticoid receptor)MR (Mineralocorticoid receptor)
Beyond the preview
Go deeper on fluticasone furoate.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fluticasone furoate.